4.6 Article

Macrophage dysfunction in the pathogenesis and treatment of asthma

Journal

EUROPEAN RESPIRATORY JOURNAL
Volume 50, Issue 3, Pages -

Publisher

EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/13993003.00196-2017

Keywords

-

Funding

  1. National Health and Medical Research Council (NHMRC) Centre of Excellence for Severe Asthma
  2. NHMRC

Ask authors/readers for more resources

Asthma is a chronic respiratory condition frequently associated with aberrant airway and systemic inflammation. Various inflammatory phenotypes in asthmatic airways have been described that relate to clinical phenotypes and impact on responses to conventional and novel asthma therapies. Macrophages are abundant immunocytes in the lung, capable of mounting diverse responses required for homeostasis and defence against pathogens. Here, we summarise the clinical evidence regarding macrophage dysfunction in asthma. We also describe evidence supporting the role of macrophages as therapeutic targets in asthma. We conclude that macrophage dysfunction in asthma is highly prevalent and heterogeneous, and hypothesise that macrophages may play roles in promoting the discrete inflammatory phenotypes of asthma. These clinical findings, along with recent ground-breaking insights into the ontogeny, behavioural complexity and longevity of pulmonary macrophages, support continued research into the role of macrophages as disease modifiers, biomarkers and therapeutic targets in asthma.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Respiratory System

Endoplasmic reticulum-unfolded protein response signalling is altered in severe eosinophilic and neutrophilic asthma

Prabuddha S. Pathinayake, David W. Waters, Kristy S. Nichol, Alexandra C. Brown, Andrew T. Reid, Alan Chen-Yu Hsu, Jay C. Horvat, Lisa G. Wood, Katherine J. Baines, Jodie L. Simpson, Peter G. Gibson, Philip M. Hansbro, Peter A. B. Wark

Summary: Research demonstrates that endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) are associated with disease severity and inflammatory phenotype in asthma.

THORAX (2022)

Editorial Material Allergy

Transcriptomic drug-response gene signatures are informative for the stratification of patients for clinical trials

Paul S. Foster, Jessica L. Barnes, Hock L. Tay, Peter G. Gibson

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Allergy

Heart rate variability as a marker of autonomic nervous system activity in young people with eosinophilic and non-eosinophilic asthma

Hajar Ali, Collin Brooks, Yu-Chieh Tzeng, Julian Crane, Richard Beasley, Peter Gibson, Philip Pattemore, Thorsten Stanley, Neil Pearce, Jeroen Douwes

Summary: This study found that autonomic nervous system activity is not associated with pathophysiology or inflammatory phenotype in young asthmatics with generally well-controlled asthma. However, enhanced sympathetic nervous system activity can be detected in asthmatics with airway hyperreactivity or who use beta-agonist medication.

JOURNAL OF ASTHMA (2023)

Review Respiratory System

Increasing physical activity in severe asthma: a systematic review and meta-analysis

Rebecca F. McLoughlin, Vanessa L. Clark, Paola D. Urroz, Peter G. Gibson, Vanessa M. McDonald

Summary: Physical inactivity is common in severe asthma and is associated with poor clinical outcomes. This systematic review and meta-analysis found that interventions such as aerobic and resistance training and pedometer-based interventions can effectively increase physical activity in adults with severe asthma, leading to improved asthma control and health-related quality of life.

EUROPEAN RESPIRATORY JOURNAL (2022)

Review Allergy

Developing the water paucity index using dimensional homogeneity

Ian D. Pavord, Peter J. Barnes, Catherine Lemiere, Peter G. Gibson

Summary: Optimizing asthma diagnosis is crucial for reducing the burden of asthma globally. A compound diagnostic approach and label are now required due to the complexity and heterogeneity of different forms of asthma. By recognizing typical symptoms and abnormal physiology, asthma can be identified, and further features such as eosinophilic or type 2 inflammation can be used to give a compound diagnostic label of eosinophilic asthma, which provides important information about future exacerbation risk and treatment responsiveness. Implementing treatable traits and using targeted assessment allows for a specific treatment plan based on a pragmatic and iterative process. (c) 2022 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology (J Allergy Clin Immunol Pract 2023;11:1-8)

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

Article Allergy

Beliefs about medicines and adherence to asthma medications during pregnancy

Vanessa E. Murphy, Annelies L. Robijn, Tommy B. Metcalfe, Thomas K. Wright, Peter G. Gibson, Kirsten McCaffery, Megan E. Jensen

Summary: This study investigated beliefs about medicines in pregnant women with asthma and their association with adherence to inhaled corticosteroids (ICS). The findings showed that ICS users were more likely to perceive that the benefits of medication use outweighed any risks, while non-adherence was not associated with having relatively more concerns about asthma medicines.

JOURNAL OF ASTHMA (2023)

Editorial Material Respiratory System

Breathlessness

Peter G. Gibson

RESPIROLOGY (2023)

Editorial Material Respiratory System

Spirometry, you have an image problem!

Peter G. G. Gibson

RESPIROLOGY (2023)

Article Respiratory System

Identifying the asthma research priorities of people with asthma, their carers and other stakeholders

Eleanor C. Majellano, Rose L. Bell, Anthony W. Flynn, Anne Mckenzie, Sundram Sivamalai, Michele Goldman, Lauren Vaughan, Peter G. Gibson

Summary: Through an online survey and consensus workshops, this study identified 10 priority research themes for asthma that reflect the needs of end-users. These findings can help bridge the gap between research priorities and the needs of people living with asthma.

RESPIROLOGY (2023)

Review Respiratory System

Vocal cord dysfunction/inducible laryngeal obstruction-2022 Melbourne Roundtable Report

Paul Leong, Peter G. Gibson, Anne E. Vertigan, Mark Hew, Vanessa M. McDonald, Philip G. Bardin

Summary: This article summarizes the discussions and recommendations of an international roundtable conference on VCD/ILO. The conference aimed to improve the consistency in diagnosis, understanding of pathogenesis, current management, and research questions for VCD/ILO. The participants highlighted the need for clear diagnostic criteria and exploration of new diagnostic technologies. The complex pathogenesis of the disease and the lack of evidence-based treatment standards were also discussed, along with the importance of multidisciplinary care models and patient perspectives.

RESPIROLOGY (2023)

Article Respiratory System

Asthma and landscape fire smoke: A Thoracic Society of Australia and New Zealand position statement

Vanessa M. Mcdonald, Gregory Archbold, Tesfalidet Beyene, Bronwyn K. Brew, Peter Franklin, Peter G. Gibson, John Harrington, Philip M. Hansbro, Fay H. Johnston, Paul D. Robinson, Michael Sutherland, Deborah Yates, Graeme R. Zosky, Michael J. Abramson

Summary: Landscape fires are becoming more frequent and severe worldwide, causing a significant health and socioeconomic burden, especially in Australia. People with asthma are especially susceptible to the effects of landscape fire smoke (LFS) exposure. This position statement highlights the impact of LFS on individuals with asthma, particularly vulnerable groups, and provides guidance on asthma management, smoke mitigation strategies, and access to air quality information during periods of LFS.

RESPIROLOGY (2023)

Review Respiratory System

Treatable traits, combination inhaler therapy and the future of asthma management

Peter G. Gibson, Vanessa M. McDonald, Dennis Thomas

Summary: The landscape of asthma has changed significantly in the last decade with the development of effective medications and inhaler devices. However, the proportion of uncontrolled patients remains high, primarily due to factors such as inappropriate use of medications, disease heterogeneity, and other contributing factors. Inhaled corticosteroids (ICS) with or without long-acting beta agonists (LABA) are currently the mainstay of asthma management. The future of asthma treatment will involve personalized medications and smart inhalers to improve adherence, inhaler technique, and polypharmacy. Precision medicine approaches, such as treatable traits (TTs), aim to identify and manage specific clinically important factors to optimize treatment. Research and validation of TTs in different clinical settings and populations are ongoing. Combination inhaler therapy and the TTs approach are complementary treatment strategies.

RESPIROLOGY (2023)

Review Respiratory System

Treatable traits for long COVID

Hayley Lewthwaite, Anthony Byrne, Bruce Brew, Peter G. Gibson

Summary: Long COVID is a new and complex chronic health condition experienced by one in eight adults following acute COVID-19. 'Treatable Traits' is a personalized medicine approach that can address the complexity and heterogeneity of this condition, by identifying and targeting the most prevalent treatable traits associated with long COVID. Current evidence supports exercise training or respiratory muscle training for long COVID treatable traits in the chest and functional limitation clusters, but further high-quality research is needed for other treatable traits.

RESPIROLOGY (2023)

Editorial Material Respiratory System

Wellness safety and burnout

Peter G. Gibson

RESPIROLOGY (2023)

Editorial Material Allergy

A Real-World Analysis to Create Real-World Change: The Need for an Individualized Approach to Improving Physical Activity in Asthma

Paola D. Urroz Guerrero, Peter G. Gibson

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

No Data Available